Dr. Summon Kaul

Bio

Dr. Summon Koul holds a Master's degree in Organic Chemistry from the University of Kashmir (1998) and a PhD from the University of Jammu (2003). During her doctoral research, she focused on isolating, characterizing, and semisynthetic conversions of biologically active natural products. After completing her PhD, she worked as a Research Associate at the Indian Institute of Science in Bengaluru, followed by a Postdoctoral Fellowship at Simon Fraser University in British Columbia, Canada, where she worked on the total synthesis of Triquinacenes.

For 13 years, Summon worked as a drug discovery Scientist and program leader at Advinus Therapeutics - a TATA Enterprise. In this role, she led in-house and collaborative drug discovery research projects with reputed multinational pharma companies such as Merck, Johnson and Johnson, USA, and Takeda, Japan. She has handled multi-crore projects and has been recognized for Best Awards in the Company. Her focus areas were Cardiovascular Diseases, Metabolic Disorders, and Inflammation. During this time, she also led CRO discovery projects in Eurofins Advinus (Advinus Therapeutics was acquired by Eurofins in 2017) in collaboration with companies like Medicines for Malaria Venture, Switzerland; Astellas, Japan; Nostrum Biodiscovery, Spain, and Foundation for Neglected Disease Research, India.

Currently, Summon has been working as a professor in the School of Consciousness for the past 2.5 years. She has over 16 publications in international journals of repute, book chapters, and eight patents to her credit.

Research Areas

Drug Discovery, Medicinal Chemistry, Natural Product Chemistry, Synthetic Organic Chemistry

Publications

1. Phytochemistry 2000, 53(2), 305-309. https://doi.org/10.1016/S0031 9422(99)00490-2

2.J. Nat. Prod., 2003, 66(8), 1121- 1123. https://doi.org/10.1021/np030070u

3. Bioorg Med Chem Lett. 2012, 22(13): 4341. https://doi.org/10.1016/j.bmcl.2012.05.020.3. 4. Tet Lett 2013, 54, 2489–2491 https://doi.org/10.1016/j.tetlet.2013.03.002

5. Bioorg. Med Chem 2017, 25, 6, 1963; https://doi.org/10.1016/j.bmc.2017.02.029

6. Bioorg Med Chem Lett., 2022, 62, 128632; https://doi.org/10.1016/j.bmcl.2022.128632

Google Scholar link :https://scholar.google.com/citations?user=EwH7H70AAAAJ&hl=en

Scopus link :https://www.scopus.com/search/form.uri?zone=TopNavBar&origin=recordpage&display=basic#basic

ORCID link :https://orcid.org/orcid-search/search?searchQuery=0000-0002-2875-7289

Research Grants

"1. SERB Core Research Grant, File No.CRG/2023/000812, Submitted in March 2023, Accepted for evaluation

2. SERB POWER Grant, File No. SPG/2022/000207, Submitted in Oct 2022, Accepted for Evaluation

3. SERB SURE Grant, File No.SUR/2022/000763, Submitted in Oct 2022"